No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels

Autor: Zheng, Kang H., Kaiser, Yannick, van Olden, Casper C., Santos, Raul D., Dasseux, Jean-Louis, Genest, Jacques, Gaudet, Daniel, Westerink, Jan, Keyserling, Constance, Verberne, Hein J., Leitersdorf, Eran, Hegele, Robert A., Descamps, Olivier S., Hopkins, Paul, Nederveen, Aart J., Stroes, Erik S.G.

Publikováno v: In Atherosclerosis October 2020 311:13-19

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial†

Autor: Tardif, Jean-Claude, Ballantyne, Christie M., Barter, Philip, Dasseux, Jean-Louis, Fayad, Zahi A., Guertin, Marie-Claude, Kastelein, John J. P., Keyserling, Constance, Klepp, Heather, Koenig, Wolfgang, L'Allier, Philippe L., Lespérance, Jacques, Lüscher, Thomas F., Paolini, John F., Tawakol, Ahmed, Waters, David D., Pfeffer, M., Brown, V., Rouleau, J., Watkins, P., Wei, L.J., Gosselin, G., Chayer, C., Lanthier, S., Pelletier, G.B., Racine, N., Agarwal, H., Brilakis, E., Cannon, L., Carrié, D., Corbelli, J., Coste, P., de Winter, R., Diaz, A., Eisenberg, S., Ennis, B., Fajadet, J., Fam, N., Fortuin, D., Gessler, C., Grines, C., Guerra, D., Gum, H., Haldis, T., Heestermans, T., Herrman, J.P., Huynh, T., Kedhi, E., Koren, M., Kouz, S., Krolick, M., Kumkumian, G., Lavi, S., Li, R.J., Masud, ARZ, McAlhany, C., McGrew, F.A., O'Shaughnessy, C., Oude Ophuis, A.J.M., Parr, K., Penny, W., Pesant, Y., Post, H., Robinson, S., Rodes-Cabau, J., Roy, A., Schulman, S., Spence, F., Stouffer, G., Stys, T., Sussex, B., Tahirkheli, N., Tardif, J-C, Grégoire, J., ten Berg, J., van Boven, A.J., von Birgelen, C., Weinstein, D.

Aim High-density lipoproteins (HDLs) have several potentially protective vascular effects. Most clinical studies of therapies targeting HDL have failed to show benefits vs. placebo. Objective To investigate the effects of an HDL-mimetic agent on athe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______805::3035249ffaeebe677fab12e8c85bc915
http://doc.rero.ch/record/303419/files/ehu171.pdf

International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis

Autor: Van Herwaarden, C.L.A., Langan, Charles E., Siemon, Gerhard, Rudolph, Claus, Keyserling, Constance H., Nemeth, Mary Anne, Tack, Kenneth J.

Publikováno v: In International Journal of Infectious Diseases 2000 4(1):26-33

Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis

Autor: Nemeth, Mary Anne, McCarty, James, Gooch, W.M., III, Henry, Dan, Keyserling, Constance H., Tack, Kenneth J.

Publikováno v: In Clinical Therapeutics 1999 21(11):1873-1881

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Autor: Tardif, Jean-Claude, Ballantyne, Christie M, Barter, Philip, Dasseux, Jean-Louis, Fayad, Zahi A, Guertin, Marie-Claude, Kastelein, John JP, Keyserling, Constance, Klepp, Heather, Koenig, Wolfgang, L'Allier, Philippe L, Lespérance, Jacques, Lüscher, Thomas F, Paolini, John F, Tawakol, Ahmed, Waters, David D, Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators

Publikováno v: European heart journal, vol 35, iss 46

AimHigh-density lipoproteins (HDLs) have several potentially protective vascular effects. Most clinical studies of therapies targeting HDL have failed to show benefits vs. placebo.ObjectiveTo investigate the effects of an HDL-mimetic agent on atheros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::9906a38f156525f6b0d143c53431cbff
https://escholarship.org/uc/item/8s06s244